Format

Send to

Choose Destination
Nat Rev Drug Discov. 2010 Jun;9(6):447-64. doi: 10.1038/nrd3137. Epub 2010 May 14.

Targeting mitochondria for cancer therapy.

Author information

1
University Children's Hospital, Ulm University, Eythstrasse 24, D-89075 Ulm, Germany. simone.fulda@uniklinik-ulm.de

Abstract

Mitochondria are the cells' powerhouse, but also their suicidal weapon store. Dozens of lethal signal transduction pathways converge on mitochondria to cause the permeabilization of the mitochondrial outer membrane, leading to the cytosolic release of pro-apoptotic proteins and to the impairment of the bioenergetic functions of mitochondria. The mitochondrial metabolism of cancer cells is deregulated owing to the use of glycolytic intermediates, which are normally destined for oxidative phosphorylation, in anabolic reactions. Activation of the cell death machinery in cancer cells by inhibiting tumour-specific alterations of the mitochondrial metabolism or by stimulating mitochondrial membrane permeabilization could therefore be promising therapeutic approaches.

PMID:
20467424
DOI:
10.1038/nrd3137
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center